BAX’s stock performance

Baxter International (BAX) is a leading provider of renal and hospital products portfolio to various healthcare companies in the US. BAX stock has seen significant growth momentum in its stock price, driven by positive developments and strong 3Q17 results on October 25, 2017.

The diagram below shows the highlights of Baxter’s 3Q17 results. On the results announcement day, the stock gained ~0.05%. The next day, BAX stock witnessed higher gains, triggered by investor confidence.

Baxter Hit a 52-Week High on October 27

On October 27, 2017, BAX stock reported a 52-week high of $65.7 per share. Investor sentiments were boosted by its strong 3Q17 quarterly results and its updated fiscal 2017 guidance.

Baxter expects a strong performance going forward and has a number of key products in its pipeline. Its recent acquisition of Clari is meanwhile expected to contribute to growth.

Baxter’s 52-week low stands at $43.1 and was reported on December 7, 2016. BAX stock has a 50-day moving average of $63.14 and a 200-day moving average of $60.25.

Comparison with industry and market

Baxter has gained ~39.2% over the past year, compared with S&P 500 Index’s return of ~21.4% and the iShares US Medical Devices’ (IHI) returns of ~28.2% during the same period.

YTD (year to date), BAX stock has gained ~48%. In the past six months, the stock has gained ~18%. Peers Thermo Fisher Scientific (TMO), Abbott Laboratories (ABT), and Boston Scientific (BSX) have gained ~36.4%, ~44.2%, and ~31.8%, respectively, on a YTD basis.

Latest articles

Marathon Petroleum (MPC) stock has been tumbling in Q3, driven by geopolitical tensions, oil price uncertainty, and weaker refining conditions.

This week, AT&T CEO Randall Stephenson noted that AT&T (T) is on track to reduce its leverage multiple to about 2.5x by the end of this year.

Jeff Bezos announced that Amazon had placed an order of 100,000 electric delivery vans from Michigan-based startup Rivian.

Bad news on the trade war front appears to have led to a fall in the broader US equity markets today. Cannabis ETFs were also trading in the red.

Energy Transfer (ET) stock has recovered in the last two trading sessions after investors hammered it on its plans to acquire SemGroup (SEMG).

Software-as-a-service company Datadog (DDOG) made a smashing debut on Wall Street yesterday. After its IPO, DDOG's shares surged 40% in intraday trading.